OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology
Xiaoguang Liu, Kaluvu Balaraman, Ciarán C. Lynch, et al.
Metabolites (2021) Vol. 11, Iss. 9, pp. 622-622
Open Access | Times Cited: 19

Showing 19 citing articles:

Recent Advances in Small Molecule Inhibitors of Deubiquitinating Enzymes
Pengwei Liu, Zhengyang Chen, Yiting Guo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117324-117324
Closed Access | Times Cited: 4

Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer
Aastha Kaushik, Somya Parashar, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102279-102279
Closed Access | Times Cited: 8

Therapeutic cysteine protease inhibitors: a patent review (2018–present)
Giulia Barchielli, Antonella Capperucci, Damiano Tanini
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 17-49
Open Access | Times Cited: 6

The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease
Liang Yú, Guangshang Zhong, Mingxin Ren, et al.
NeuroMolecular Medicine (2023) Vol. 25, Iss. 4, pp. 471-488
Closed Access | Times Cited: 15

Posttranslational Modifications ofα-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases
Kambiz Hassanzadeh, Jun Liu, Santhosh Chandar Maddila, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1254-1290
Closed Access | Times Cited: 5

USP13: Multiple Functions and Target Inhibition
Xiaolong Li, Ge Yang, Wenyao Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20

Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases
Ankit Siwach, Harit Patel, Amit Khairnar, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access

USP13: A therapeutic target for combating tumorigenesis and antitumor therapy resistance
Lina Yi, Akezhouli Shahatiaili, Lin Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 140608-140608
Closed Access

Role of USP13 in physiology and diseases
Qian Wang, Zhenzhen Sun, Weiwei Xia, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 15

Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
Pernille Y. Ø. Nielsen, Justyna Okarmus, Morten Meyer
Cells (2023) Vol. 12, Iss. 4, pp. 651-651
Open Access | Times Cited: 9

An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic Target
Guangce Xia, Yulin Guo, Jiajia Zhang, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 9, pp. 708-718
Open Access | Times Cited: 2

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Biying Qin, Xiaohong Chen, Feng Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2

Amorfrutin B Protects Mouse Brain Neurons from Hypoxia/Ischemia by Inhibiting Apoptosis and Autophagy Processes Through Gene Methylation- and miRNA-Dependent Regulation
Karolina Przepiórska, Agnieszka Wnuk, Cordian Beyer, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 2, pp. 576-595
Open Access | Times Cited: 11

USP13 regulates cell senescence through mediating MDM2 stability
Jinshan He, Boina Baoyinna, Sarah Taleb, et al.
Life Sciences (2023) Vol. 331, pp. 122044-122044
Open Access | Times Cited: 6

Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice
Xiaoguang Liu, Kaluvu Balaraman, Ciarán C. Lynch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8131-8131
Open Access | Times Cited: 8

Targeting Deubiquitinating Enzymes (DUBs) That Regulate Mitophagy via Direct or Indirect Interaction with Parkin
Eliona Tsefou, Robin Ketteler
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12105-12105
Open Access | Times Cited: 4

Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review)
Yun Tao, Xiaohong Xu, Rong Shen, et al.
Oncology Letters (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 2

α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
Hung-Hsiang Ho, Simon S. Wing
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access

Epigenetics of Brain Disorders
Ali Jawaid, Eloïse A. Kremer, Nancy V. N. Carullo, et al.
Elsevier eBooks (2022), pp. 737-759
Closed Access

Page 1

Scroll to top